Dawang, Rosalia L.

HRN: 26-00-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2024
AZITHROMYCIN 500MG TABLET (TAB)
10/09/2024
10/13/2024
PO
500 Mg/tab, 1 Tab
OD
Community Acquired Pneumonia
Waiting Final Action 
10/09/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/09/2024
10/16/2024
IV
4.5g
Q8
UTI; CAP-HR
Waiting Final Action 
10/13/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
10/13/2024
10/17/2024
IV
500mg
OD
CAP Hr
Waiting Final Action 
10/19/2024
LEVOFLOXACIN 500MG (TAB)
10/19/2024
10/25/2024
PO
500
OD
Pneumonia
Waiting Final Action 
10/19/2024
MUPIROCIN 2%, 15G (TUBE)
10/19/2024
10/26/2024
TOPICAL
2%
BID
Infected Sacral Ulcer
Waiting Final Action 
10/22/2024
MUPIROCIN 2%, 15G (TUBE)
10/21/2024
10/28/2024
TOPICAL
2%
BID
Infected Sacral Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: